Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genes

Genomics

Volumn 80, Issue 3, 2002, Pages 303-310

  Powell, Jason A ^a,b   Gardner, Alison E ^a   Bais, Anthony J ^a   Hinze, Susan J ^a,c   Baker, Elizabeth ^a   Whitmore, Scott ^a,c   Crawford, Joanna ^a,c   Kochetkova, Marina ^a   Spendlove, Hayley E ^a   Doggett, Norman A ^d   Sutherland, Grant R ^a,b   Callen, David F ^a,c   Kremmidiotis, Gabriel ^a,b,c  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Bionomics   (Australia)

^d LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

16q24.3; Breast cancer; LOH; Tumor suppressor

Indexed keywords

MESSENGER RNA;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CHROMOSOME 16Q; CONTROLLED STUDY; DNA SEQUENCE; EPITHELIOID CELL; GENE IDENTIFICATION; GENE MAPPING; GENE SEQUENCE; GENETIC STRAIN; GENETIC TRANSCRIPTION; HETEROZYGOSITY; HUMAN; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE GENETICS; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE;

EID: 18544369009     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2002.6828     Document Type: Article

References (48)

1. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumours reveals factors that influence delineation of candidate regions
2. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers
3. Identification of a 910-kb region of common allelic loss in chromosome bands 16q24.1-q24.2 in human lung cancer
4. Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan
5. Chromosome band 16q24 is frequently deleted in human gastric cancer
6. Cervical metastases of head and neck squamous cell carcinoma correlate with loss of heterozygosity on chromosome 16q
7. Allelotype of pediatric rhabdomyosarcoma
8. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: Refining a putative tumour suppressor gene region
9. Somatic genetic changes in human breast cancer
10. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread
11. Genomic structure and expression analysis of the spastic paraplegia gene, SPG7
12. Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes
13. Characterization of copine VII, a new member of the copine family, and its exclusion as a candidate in sporadic breast cancers with loss of heterozygosity at 16q24.3
14. The PISSLRE gene: Structure, exon skipping, and exclusion as tumour suppressor in breast cancer
15. Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3
16. Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer
17. Nonsense-mediated decay of human HEXA mRNA
18. Cloning and mutation analysis of the human IL-18 promoter: A possible role of polymorphisms in expression regulation
19. Isolation of DICE1: A gene frequently affected by LOH and downregulated in lung carcinomas
20. Hypermethylation leads to silencing of the SYK gene in human breast cancer
21. Construction of a high-resolution physical and transcription map of chromosome 16q24.3: A region of frequent loss of heterozygosity in sporadic breast cancer
22. Integration of transcript and genetic maps of chromosome 16 at near-1-Mb resolution: Demonstration of a "hot spot" for recombination at 16p12
23. Initial sequencing and analysis of the human genome
24. Incognito rRNA and rDNA in databases and libraries
25. The SYK tyrosine kinase suppresses malignant growth of human breast cancer cells
26. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas
27. The sequence of the human genome
28. An evaluation of the draft human genome sequence
29. The highest gene concentrations in the human genome are in telomeric bands of metaphase chromosomes
30. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization
31. Junctions of AML1/CBFA2T1(ETO) fusion are constant in t(8-21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction
32. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the CBFA2T1(ETO) family
33. Multiple regions of ETO cooperate in transcriptional repression
34. Molecular analysis of 9 new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22(phox)
35. NAD(P)H oxidases and their relevance to atherosclerosis
36. Hypoxia and oxidative stress in breast cancer. Oxidative stress: Its effects on the growth, metastatic potential and response to therapy of breast cancer
37. Hydrogen peroxide in relation to proliferation and apoptosis in BHK-21 hamster fibroblasts
38. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1
39. Reactive oxygen species and programmed cell death
40. Reactive oxygen species as mediators of angiotensin II signaling
41. Identification of a YAC from 16q24 carrying a senescence gene for breast cancer cells
42. The ubiquitin-proteasome pathway in cancer
43. Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity
44. Base-calling of automated sequencer traces using phred. I. Accuracy assessment
45. The Staden package, 1998
46. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
47. Defining regions of loss of heterozygosity of 16q in breast cancer cell lines
48. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays